array biopharma inc
(ARRY:Consolidated Issue listed on NASDAQ Global Market)
Jonathan Kay M.D.
Member of Scientific Advisory Board, Array BioPharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 10 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Jonathan Kay,,M.D. serves as Director of Clinical Trials in the MGH Rheumatology Unit and an Associate Clinical Professor of Medicine at Harvard. Dr. Kay has been a principal investigator on over 30 clinical trials of novel therapies for rheumatoid arthritis, gout and osteoarthritis. He has been a Member Scientific Advisory Board of Array Biopharma Inc. since May 2007. He is the author of more than 50 publications and book chapters and is internationally recognized as ...
3200 Walnut StreetPhone: 303-381-6600
Boulder, Colorado 80301
Board Members Memberships*There is no Board Members Memberships data available.
University of California, San Francisco School of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jack Lief Ph.D.||Co-Founder, Chairman, Chief Executive Officer and President|
Arena Pharmaceuticals, Inc.
|Harvey J. Berger M.D.||Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Werner Lanthaler MBA,MPA||Chief Executive Officer and Member of Management Board|
|€601.0K||Compensation as of Fiscal Year 2013.|